APA (7th ed.) Citation

Min Tang, Yue Wang, Pulin Li, Rui Han, & Ran Wang. (2024). Assessing the benefits and safety profile of incorporating poly ADP-ribose polymerase (PARP) inhibitors in the treatment of advanced lung cancer: A thorough systematic review and meta-analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Min Tang, Yue Wang, Pulin Li, Rui Han, and Ran Wang. Assessing the Benefits and Safety Profile of Incorporating Poly ADP-ribose Polymerase (PARP) Inhibitors in the Treatment of Advanced Lung Cancer: A Thorough Systematic Review and Meta-analysis. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Min Tang, et al. Assessing the Benefits and Safety Profile of Incorporating Poly ADP-ribose Polymerase (PARP) Inhibitors in the Treatment of Advanced Lung Cancer: A Thorough Systematic Review and Meta-analysis. Frontiers Media S.A., 2024.